Fast-track plan for newly-developed fibres
Fast-track plan for newly-developed fibres
Stay updated with breaking news from Origin Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fast-track plan for newly-developed fibres
Origin.Bio-- a synthetic biology company that replicates and improves ingredients from traditional chemical industrialisation processes, freeing manufacturers from petrochemical dependency -- toda ...
Origin.Bio announced today that it has secured $15 million of funding led by EQT Ventures. The company plans to use the funding to expand technology and bring sustainable ingredients to brands all over the world.
Origin.Bio, a Munich, Germany-based synthetic biology company, raised $15m in funding. The round was led by EQT Ventures with participation from existing investor BlueYard Capital and new investors Taavet Hinrikus and Sten Tamkivi, Acequia Capital, Inventures and Charlie Songhurst. The company intends to use the funds to expand the technology and team. Founded by Jens Klein, CEO, Origin.Bio is a synthetic biology company which creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialisation processes but with less energy requirements and ...